News Quantified

EVFM – evofem bioscience inc (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE

Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates [Yahoo! Finance]

Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates

Evofem Biosciences Honors World Contraception Day [Yahoo! Finance]

Evofem Biosciences Honors World Contraception Day

Form 8-K Evofem Biosciences, Inc. For: Nov 26

Form DEF 14A Evofem Biosciences, Inc. For: Oct 29

Form PRE 14A Evofem Biosciences, Inc. For: Oct 20

Form 8-K Evofem Biosciences, Inc. For: Oct 20

Form 8-K Evofem Biosciences, Inc. For: Oct 13

Top News Gainers

5/7 Form 424B3 Evofem Biosciences, Inc. 24.7%

5/10 Form DEFR14A Evofem Biosciences, Inc. 16.9%

12/2 Evofem Biosciences Reports Positive Top-Line Results from Phase 2b Study of Amphora® for Prevention of Chlamydia and Gonorrhea in Women 12.3%

3/25 Evofem Biosciences Adopts Shareholder Rights Agreement 10.2%

4/17 Form 8-K Evofem Biosciences, Inc. For: Apr 14 9.8%

5/29 Evofem Biosciences Inc (NASDAQ: EVFM) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 8.8%

5/28 Evofem Biosciences Inc (NASDAQ: EVFM) was given a new $9.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 6.5%

5/14 Evofem Biosciences to Present at 2019 RBC Capital Markets Global Healthcare Conference 6.3%

3/30 Form DEF 14A Evofem Biosciences, Inc. For: May 12 6.0%

1/10 Form 8-K Evofem Biosciences, Inc. For: Jan 10 5.7%

Top News Decliners

7/1 Evofem Biosciences Added to Russell 3000® Index -16.5%

12/31 Form 4 Evofem Biosciences, Inc. For: Dec 31 Filed by: Lynch Thomas G -13.5%

12/2 UPDATE: Evofem Biosciences stock soars 27% premarket on news of positive results in trial of drugs for STDs [MarketWatch] -12.4%

3/12 Q4/2019 12/31/2019 EPS -0.270 ZacksConsensus -0.290 ActVsEst 0.020 - Beat -12.0%

6/24 Form S-3 Evofem Biosciences, Inc. -9.7%

4/28 Evofem Biosciences to Report First Quarter 2020 Results and Provide Corporate Update on Wednesday, May 6, 2020 -7.3%

4/27 Evofem Biosciences Secures up to $25 Million in Convertible Note Financing -6.6%

5/12 Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -6.0%

4/2 Evofem Biosciences Inc (NASDAQ: EVFM) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.3%

11/26 Form 8-K Evofem Biosciences, Inc. For: Nov 26 -5.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day